Vantage logo

Covid-19 hits Europe drug stocks hardest

US drug stocks were shielded from bigger falls in the first quarter by leading coronavirus researchers, leaving groups listed in Japan and Europe to tumble harder.

Vantage logo

Zepsyre has a path to market at last

Pharmamar says the US FDA has given an accelerated approval filing plan its blessing, and that means a regulatory submission this year.